Search

Your search keyword '"Kuter, Irene"' showing total 149 results
Start Over Author "Kuter, Irene"
149 results on '"Kuter, Irene"'

2. Supplementary Table 2 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table 1 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Tables 7 - 8 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figures 1 - 3 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure Legends, Table Legends from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Tables 3 - 6 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

8. Data from A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Author

Kuemmel, Sherko, primary, Campone, Mario, primary, Loirat, Delphine, primary, Lopez, Rafael Lopez, primary, Beck, J. Thaddeus, primary, De Laurentiis, Michelino, primary, Im, Seock-Ah, primary, Kim, Sung-Bae, primary, Kwong, Ava, primary, Steger, Guenther G., primary, Adelantado, Esther Zamora, primary, Duhoux, Francois P., primary, Greil, Richard, primary, Kuter, Irene, primary, Lu, Yen-Shen, primary, Tibau, Ariadna, primary, Özgüroğlu, Mustafa, primary, Scholz, Christian W., primary, Singer, Christian F., primary, Vega, Estela, primary, Wimberger, Pauline, primary, Zamagni, Claudio, primary, Couillebault, Xuan-Mai, primary, Fan, Liqiong, primary, Guerreiro, Nelson, primary, Mataraza, Jennifer, primary, Sand-Dejmek, Janna, primary, and Chan, Arlene, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Data from A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Author

Kuemmel, Sherko, primary, Campone, Mario, primary, Loirat, Delphine, primary, Lopez, Rafael Lopez, primary, Beck, J. Thaddeus, primary, De Laurentiis, Michelino, primary, Im, Seock-Ah, primary, Kim, Sung-Bae, primary, Kwong, Ava, primary, Steger, Guenther G., primary, Adelantado, Esther Zamora, primary, Duhoux, Francois P., primary, Greil, Richard, primary, Kuter, Irene, primary, Lu, Yen-Shen, primary, Tibau, Ariadna, primary, Özgüroğlu, Mustafa, primary, Scholz, Christian W., primary, Singer, Christian F., primary, Vega, Estela, primary, Wimberger, Pauline, primary, Zamagni, Claudio, primary, Couillebault, Xuan-Mai, primary, Fan, Liqiong, primary, Guerreiro, Nelson, primary, Mataraza, Jennifer, primary, Sand-Dejmek, Janna, primary, and Chan, Arlene, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Tables 11 - 13 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Tables 9 - 10 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., primary, Anderson, Helen, primary, Ghazoui, Zara, primary, Ribas, Ricardo, primary, Anderson, Elizabeth, primary, Gao, Qiong, primary, A'hern, Roger, primary, Mackay, Alan, primary, Lindemann, Justin, primary, Wellings, Robert, primary, Walker, Jill, primary, Kuter, Irene, primary, Martin, Lesley-Ann, primary, and Dowsett, Mitch, primary

Published
2023
Full Text
View/download PDF

17. A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.

Author

UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, Kuemmel, Sherko, Campone, Mario, Loirat, Delphine, Lopez, Rafael Lopez, Beck, J Thaddeus, De Laurentiis, Michelino, Im, Seock-Ah, Kim, Sung-Bae, Kwong, Ava, Steger, Guenther G, Adelantado, Esther Zamora, Duhoux, Francois, Greil, Richard, Kuter, Irene, Lu, Yen-Shen, Tibau, Ariadna, Özgüroğlu, Mustafa, Scholz, Christian W, Singer, Christian F, Vega, Estela, Wimberger, Pauline, Zamagni, Claudio, Couillebault, Xuan-Mai, Fan, Liqiong, Guerreiro, Nelson, Mataraza, Jennifer, Sand-Dejmek, Janna, Chan, Arlene, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, Kuemmel, Sherko, Campone, Mario, Loirat, Delphine, Lopez, Rafael Lopez, Beck, J Thaddeus, De Laurentiis, Michelino, Im, Seock-Ah, Kim, Sung-Bae, Kwong, Ava, Steger, Guenther G, Adelantado, Esther Zamora, Duhoux, Francois, Greil, Richard, Kuter, Irene, Lu, Yen-Shen, Tibau, Ariadna, Özgüroğlu, Mustafa, Scholz, Christian W, Singer, Christian F, Vega, Estela, Wimberger, Pauline, Zamagni, Claudio, Couillebault, Xuan-Mai, Fan, Liqiong, Guerreiro, Nelson, Mataraza, Jennifer, Sand-Dejmek, Janna, and Chan, Arlene

Abstract

This phase II study determined the efficacy of lacnotuzumab added to gemcitabine plus carboplatin (gem-carbo) in patients with advanced triple-negative breast cancer (TNBC). Female patients with advanced TNBC, with high levels of tumor-associated macrophages not amenable to curative treatment by surgery or radiotherapy were enrolled. Lacnotuzumab was dosed at 10 mg/kg every 3 weeks, ± a dose on cycle 1, day 8. Gemcitabine (1,000 mg/m) and carboplatin (dose in mg calculated by area under the curve [mg/mL/min] × (glomerular filtration rate [mL/min] + 25 [mL/min]) were dosed every 3 weeks. Treatment continued until unacceptable toxicity, disease progression, or discontinuation by physician/patient. Patients received lacnotuzumab + gem-carbo ( = 34) or gem-carbo ( = 15). Enrollment was halted due to recruitment challenges owing to rapid evolution of the therapeutic landscape; formal hypothesis testing of the primary endpoint was therefore not performed. Median progression-free survival was 5.6 months [90% confidence interval (CI), 4.47-8.64] in the lacnotuzumab + gem-carbo arm and 5.5 months (90% CI, 3.45-7.46) in the gem-carbo arm. Hematologic adverse events were common in both treatment arms; however, patients treated with lacnotuzumab experienced more frequent aspartate aminotransferase, alanine aminotransferase, and creatine kinase elevations. Pharmacokinetic results showed that free lacnotuzumab at 10 mg/kg exhibited a typical IgG pharmacokinetic profile and target engagement of circulating colony-stimulating factor 1 ligand. Despite successful target engagement and anticipated pharmacokinetic profile, lacnotuzumab + gem-carbo showed comparable antitumor activity to gem-carbo alone, with slightly poorer tolerability. However, the data presented in this article would be informative for future studies testing agents targeting the CSF1-CSF1 receptor pathway in TNBC.

Published
2022

18. Abstract PD5-11: Pilot study to assess prolonged nightly fasting in breast cancer survivors (LONGFAST)

Author

O'Donnell, Elizabeth K., primary, Shapiro, Yael N., additional, Comander, Amy, additional, Isakoff, Steven J., additional, Moy, Beverly, additional, Spring, Laura, additional, Wander, Seth, additional, Kuter, Irene, additional, Shin, Jennifer, additional, Younger, Jerry, additional, Specht, Michelle, additional, Kourniotis, Chryssanthi, additional, Sullivan, Carol, additional, Winters, Loren, additional, Horick, Nora, additional, and Peppercorn, Jeffrey, additional

Published
2022
Full Text
View/download PDF

19. sj-docx-1-tam-10.1177_17588359221119370 – Supplemental material for Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

Author

Denault, Elyssa, Nakajima, Erika, Naranbhai, Vivek, Hutchinson, Jennifer A., Mortensen, Lindsey, Neihoff, Elizabeth, Barabell, Caroline, Comander, Amy, Juric, Dejan, Kuter, Irene, Mulvey, Theresa, Peppercorn, Jeffrey, Rosenstock, Aron S., Shin, Jennifer, Vidula, Neelima, Wander, Seth A., Moy, Beverly, Ellisen, Leif W., Isakoff, Steven J., Iafrate, A. John, Gainor, Justin F., Bardia, Aditya, and Spring, Laura M.

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-1-tam-10.1177_17588359221119370 for Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer by Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Jennifer A. Hutchinson, Lindsey Mortensen, Elizabeth Neihoff, Caroline Barabell, Amy Comander, Dejan Juric, Irene Kuter, Theresa Mulvey, Jeffrey Peppercorn, Aron S. Rosenstock, Jennifer Shin, Neelima Vidula, Seth A. Wander, Beverly Moy, Leif W. Ellisen, Steven J. Isakoff, A. John Iafrate, Justin F. Gainor, Aditya Bardia and Laura M. Spring in Therapeutic Advances in Medical Oncology

Published
2022
Full Text
View/download PDF

21. A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Author

Kuemmel, Sherko, primary, Campone, Mario, additional, Loirat, Delphine, additional, Lopez, Rafael Lopez, additional, Beck, J. Thaddeus, additional, De Laurentiis, Michelino, additional, Im, Seock-Ah, additional, Kim, Sung-Bae, additional, Kwong, Ava, additional, Steger, Guenther G., additional, Adelantado, Esther Zamora, additional, Duhoux, Francois P., additional, Greil, Richard, additional, Kuter, Irene, additional, Lu, Yen-Shen, additional, Tibau, Ariadna, additional, Özgüroğlu, Mustafa, additional, Scholz, Christian W., additional, Singer, Christian F., additional, Vega, Estela, additional, Wimberger, Pauline, additional, Zamagni, Claudio, additional, Couillebault, Xuan-Mai, additional, Fan, Liqiong, additional, Guerreiro, Nelson, additional, Mataraza, Jennifer, additional, Sand-Dejmek, Janna, additional, and Chan, Arlene, additional

Published
2022
Full Text
View/download PDF

22. Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

Author

Denault, Elyssa, primary, Nakajima, Erika, additional, Naranbhai, Vivek, additional, Hutchinson, Jennifer A., additional, Mortensen, Lindsey, additional, Neihoff, Elizabeth, additional, Barabell, Caroline, additional, Comander, Amy, additional, Juric, Dejan, additional, Kuter, Irene, additional, Mulvey, Theresa, additional, Peppercorn, Jeffrey, additional, Rosenstock, Aron S., additional, Shin, Jennifer, additional, Vidula, Neelima, additional, Wander, Seth A., additional, Moy, Beverly, additional, Ellisen, Leif W., additional, Isakoff, Steven J., additional, Iafrate, A. John, additional, Gainor, Justin F., additional, Bardia, Aditya, additional, and Spring, Laura M., additional

Published
2022
Full Text
View/download PDF

25. Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast).

Author

O'Donnell, Elizabeth, Shapiro, Yael, Comander, Amy, Isakoff, Steven, Moy, Beverly, Spring, Laura, Wander, Seth, Kuter, Irene, Shin, Jennifer, Specht, Michelle, Kournioti, Chryssanthi, Hu, Bonnie, Sullivan, Carol, Winters, Loren, Horick, Nora, and Peppercorn, Jeffrey

Abstract

Purpose: Retrospective analysis of nightly fasting among women with breast cancer suggests that fasting < 13 h may be associated with a higher risk of breast cancer recurrence. We sought to evaluate prolonged overnight fasting (POF), an accessible nonpharmacological intervention, in a prospective feasibility study. Methods: We designed a single-arm, pilot study to evaluate the feasibility of fasting for 13 h overnight for 12 weeks among women with a history of early-stage breast cancer survivors. Baseline and end of study assessments included measurements of body mass index (BMI), blood biomarkers, quality of life (QOL), mood, fatigue, and physical activity. Patient-reported outcome questionnaires were also administered at 6 weeks. Feasibility was defined as ≥ 60% of participants documenting fasting for 13 h on at least 70% of nights during the study period. Results: Forty women with a history of breast cancer were enrolled with a median age of 60 (range 35–76) and median time since diagnosis of 4.5 years (range 0.8–20.7). At baseline, BMI was ≥ 25 in 37.5%. Ninety-five percent of participants fasted ≥ 13 h for at least 70% of study days (95% CI 83–99%). There was a statistically significant improvement in anxiety (p = 0.0007) at 6 weeks and BMI (p = 0.0072), anxiety (p = 0.0141), depression (p = 0.0048), and fatigue (p = 0.0105) at 12 weeks. There was no significant change in overall QOL, physical activity levels, or blood biomarkers at 12 weeks. Conclusions: POF is feasible among patients with a history of breast cancer and may potentially improve BMI, mood, and fatigue without detrimental effects on overall QOL. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

26. Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience

Author

Wander, Seth A., primary, Han, Hyo S., additional, Zangardi, Mark L., additional, Niemierko, Andrzej, additional, Mariotti, Veronica, additional, Kim, Leslie S.L., additional, Xi, Jing, additional, Pandey, Apurva, additional, Dunne, Siobhan, additional, Nasrazadani, Azadeh, additional, Kambadakone, Avinash, additional, Stein, Casey, additional, Lloyd, Maxwell R., additional, Yuen, Megan, additional, Spring, Laura M., additional, Juric, Dejan, additional, Kuter, Irene, additional, Sanidas, Ioannis, additional, Moy, Beverly, additional, Mulvey, Therese, additional, Vidula, Neelima, additional, Dyson, Nicholas J., additional, Ellisen, Leif W., additional, Isakoff, Steven, additional, Wagle, Nikhil, additional, Brufsky, Adam, additional, Kalinsky, Kevin, additional, Ma, Cynthia X., additional, O’Shaughnessy, Joyce, additional, and Bardia, Aditya, additional

Published
2021
Full Text
View/download PDF

27. Abstract PS18-19: Comparison of metastatic genomic profile in patients ≤45 years and patients &gt;45 years with triple-negative breast cancer

Author

Vidula, Neelima, primary, Niemierko, Andrzej, additional, Hesler, Katherine, additional, Isakoff, Steven, additional, Juric, Dejan, additional, Shin, Jennifer, additional, Spring, Laura, additional, Peppercorn, Jeffrey, additional, Younger, Jerry, additional, Kuter, Irene, additional, Moy, Beverly, additional, Ellisen, Leif W., additional, and Bardia, Aditya, additional

Published
2021
Full Text
View/download PDF

31. Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study

Author

Burstein, Harold J., Harris, Lyndsay N., Gelman, Rebecca, Lester, Susan C., Nunes, Raquel A., Kaelin, Carolyn M., Parker, Leroy M., Ellisen, Leif W., Kuter, Irene, Gadd, Michele A., Christian, Roger L., Kennedy, Patricia Rae, Borges, Virginia F., Bunnell, Craig A., Younger, Jerry, Smith, Barbara L., and Winer, Eric P.

Published
2003

36. A 57-year-old man with a 20-year history of episodic headache, flushing, hypotension, and occasional syncope

Author

Kuter, Irene and Harris, Nancy L.

Subjects
Mast cell disease -- Case studies
Abstract

A 57-year-old man was diagnosed with systemic mastocytosis. He was admitted to the hospital suffering from low blood pressure and tightness in his chest. He had a 20-year history of headaches, flushing, tear discharge, low blood pressure and occasional fainting. The patient had a series of tests in the hospital, but he was discharged without a diagnosis. A follow-up examination found that the patient had an enlarged spleen, and a bone marrow biopsy indicated that he had indolent systemic mastocytosis. Systemic mastocytosis is a disorder in which mast cells, connective tissue cells involved in allergic reactions, move into the skin, lymph nodes, bone, blood, spleen and liver. Patients with this disease have 15- to 30-minute attacks with flushing, lightheadedness and heart palpitations. Other symptoms during attacks include headaches, chest pain, nausea, diarrhea and breathing difficulties. Seventy percent of patients with indolent systemic mastocytosis survive at least 10 years after diagnosis.

Published
1992

37. A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC).

Author

Wander, Seth Andrew, primary, Zangardi, Mark, additional, Niemierko, Andrzej, additional, Kambadakone, Avinash, additional, Kim, Leslie SL, additional, Xi, Jing, additional, Pandey, Apurva Kumari, additional, Spring, Laura, additional, Stein, Casey, additional, Juric, Dejan, additional, Kuter, Irene, additional, Moy, Beverly, additional, Mulvey, Therese Marie, additional, Vidula, Neelima, additional, Isakoff, Steven J., additional, Yuen, Megan, additional, Brufsky, Adam, additional, Ma, Cynthia X., additional, O'Shaughnessy, Joyce, additional, and Bardia, Aditya, additional

Published
2019
Full Text
View/download PDF

38. Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer

Author

Emens, Leisha A., primary, Cruz, Cristina, additional, Eder, Joseph Paul, additional, Braiteh, Fadi, additional, Chung, Cathie, additional, Tolaney, Sara M., additional, Kuter, Irene, additional, Nanda, Rita, additional, Cassier, Philippe A., additional, Delord, Jean-Pierre, additional, Gordon, Michael S., additional, ElGabry, Ehab, additional, Chang, Ching-Wei, additional, Sarkar, Indrani, additional, Grossman, William, additional, O’Hear, Carol, additional, Fassò, Marcella, additional, Molinero, Luciana, additional, and Schmid, Peter, additional

Published
2019
Full Text
View/download PDF

39. Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses

Author

Schmid, Peter, primary, Cruz, Cristina, additional, Braiteh, Fadi S., additional, Eder, Joseph Paul, additional, Tolaney, Sara, additional, Kuter, Irene, additional, Nanda, Rita, additional, Chung, Cathie, additional, Cassier, Philippe, additional, Delord, Jean-Pierre, additional, Gordon, Michael, additional, Li, Yijin, additional, Liu, Bo, additional, O’Hear, Carol, additional, Fasso, Marcella, additional, Molinero, Luciana, additional, and Emens, Leisha A., additional

Published
2017
Full Text
View/download PDF

40. Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab

Author

Putt, Mary, primary, Hahn, Virginia Shalkey, primary, Januzzi, James L, primary, Sawaya, Heloisa, primary, Sebag, Igal A, primary, Plana, Juan Carlos, primary, Picard, Michael H, primary, Carver, Joseph R, primary, Halpern, Elkan F, primary, Kuter, Irene, primary, Passeri, Jonathan, primary, Cohen, Victor, primary, Banchs, Jose, primary, Martin, Randolph P, primary, Gerszten, Robert E, primary, Scherrer-Crosbie, Marielle, primary, and Ky, Bonnie, primary

Published
2015
Full Text
View/download PDF

41. LONGITUDINAL CHANGES IN MULTIPLE BIOMARKERS ARE ASSOCIATED WITH CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN, TAXANES AND TRASTUZUMAB

Author

Hahn, Virginia Shalkey, primary, Putt, Mary, additional, Sawaya, Heloisa, additional, Januzzi, James, additional, Sebag, Igal A., additional, Plana, Juan, additional, Picard, Michael, additional, Gerszten, Robert, additional, Halpern, Elkan, additional, Kuter, Irene, additional, Martin, Randolph, additional, Carver, Joseph, additional, Scherrer-Crosbie, Marielle, additional, and Ky, Bonnie, additional

Published
2015
Full Text
View/download PDF

42. Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Author

Patani, Neill, primary, Dunbier, Anita K., additional, Anderson, Helen, additional, Ghazoui, Zara, additional, Ribas, Ricardo, additional, Anderson, Elizabeth, additional, Gao, Qiong, additional, A'hern, Roger, additional, Mackay, Alan, additional, Lindemann, Justin, additional, Wellings, Robert, additional, Walker, Jill, additional, Kuter, Irene, additional, Martin, Lesley-Ann, additional, and Dowsett, Mitch, additional

Published
2014
Full Text
View/download PDF

43. Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab

Author

Ky, Bonnie, primary, Putt, Mary, additional, Sawaya, Heloisa, additional, French, Benjamin, additional, Januzzi, James L., additional, Sebag, Igal A., additional, Plana, Juan Carlos, additional, Cohen, Victor, additional, Banchs, Jose, additional, Carver, Joseph R., additional, Wiegers, Susan E., additional, Martin, Randolph P., additional, Picard, Michael H., additional, Gerszten, Robert E., additional, Halpern, Elkan F., additional, Passeri, Jonathan, additional, Kuter, Irene, additional, and Scherrer-Crosbie, Marielle, additional

Published
2014
Full Text
View/download PDF

46. Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

Author

Sawaya, Heloisa, primary, Sebag, Igal A., additional, Plana, Juan Carlos, additional, Januzzi, James L., additional, Ky, Bonnie, additional, Tan, Timothy C., additional, Cohen, Victor, additional, Banchs, Jose, additional, Carver, Joseph R., additional, Wiegers, Susan E., additional, Martin, Randolph P., additional, Picard, Michael H., additional, Gerszten, Robert E., additional, Halpern, Elkan F., additional, Passeri, Jonathan, additional, Kuter, Irene, additional, and Scherrer-Crosbie, Marielle, additional

Published
2012
Full Text
View/download PDF

48. VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy

Author

Burstein, Harold J., primary, Chen, Yu-Hui, additional, Parker, Leroy M., additional, Savoie, Jennifer, additional, Younger, Jerry, additional, Kuter, Irene, additional, Ryan, Paula D., additional, Garber, Judy E., additional, Chen, Helen, additional, Campos, Susana M., additional, Shulman, Lawrence N., additional, Harris, Lyndsay N., additional, Gelman, Rebecca, additional, and Winer, Eric P., additional

Published
2008
Full Text
View/download PDF

50. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer

Author

Burstein, Harold J., primary, Bellon, Jennifer R., additional, Galper, Sharon, additional, Lu, Hsiao-Ming, additional, Kuter, Irene, additional, Taghian, Alphonse G., additional, Wong, Julia, additional, Gelman, Rebecca, additional, Bunnell, Craig A., additional, Parker, Leroy M., additional, Garber, Judy E., additional, Winer, Eric P., additional, Harris, Jay R., additional, and Powell, Simon N., additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results